...
首页> 外文期刊>Genomics >Association between microRNA binding site polymorphisms in immunoinflammatory genes and recurrence risk of ischemic stroke
【24h】

Association between microRNA binding site polymorphisms in immunoinflammatory genes and recurrence risk of ischemic stroke

机译:免疫炎基因微瘤结合位点多态性的关系,缺血性卒中复发风险

获取原文
           

摘要

MicroRNA binding site polymorphisms in immunoinflammatory genes have been implicated as candidate biomarkers for prediction of complex human diseases. However, the roles of microRNA binding site polymorphisms in stroke onset and prognosis remain unclear. Thus, for the first time, five potential functional polymorphisms in immunoinflammatory genes (CXCR2 rs1126579, TLR4 rs11536889, ADIPOR2 rs12342, MMP-2 rs7201 and MMP-9 rs1056628) were genotyped in 657 patients with ischemic stroke. These five polymorphisms were not related with age onset of ischemic stroke. However, we found that ADIPOR2 rs12342 was significantly associated with a decreased recurrence risk, especially for the patients with small-vessel disease. Moreover, by using multivariate Cox regression, the variant genotype GG/GA of rs12342 was observed as an independent protective factor for stroke recurrence, even after Bonferroni correction. In addition, after the addition of rs12342 in the model with clinical factors, the new model showed the improved discriminatory ability to predict stroke recurrence. In short, our results suggested that ADIPOR2 rs12342 may be a novel genetic biomarker and therapeutic target for ischemic stroke recurrence. Further studies are required to replicate our findings and clarify the potential biological mechanism.
机译:免疫炎基因中的MicroRNA结合位点多态性涉及用于预测复杂人类疾病的候选生物标志物。然而,MicroRNA结合位点多态性在中风发作和预后的作用仍然尚不清楚。因此,在657例缺血性卒中患者中,首次在免疫炎基因中的五种潜在的功能多态性(CXCR2 RS1126579,TLR4 RS11536889,Adipor2 RS12342,MMP-2 RS7201和MMP-9 rs1056628)进行了基因分型。这五种多态性与缺血性卒中的年龄不相关。然而,我们发现adipor2 rs12342与减少的复发风险显着相关,特别是对于小血管疾病的患者而言。此外,通过使用多变量COX回归,即使在Bonferroni校正之后,观察到RS12342的变体基因型GG / GA为卒中复发的独立保护因子。此外,在临床因素的模型中添加Rs12342后,新模型显示出改善的歧视性能力,以预测中风复发。简而言之,我们的结果表明adipor2 rs12342可以是一种新型遗传生物标志物和缺血性卒中复发治疗靶标。需要进一步的研究来复制我们的发现并阐明潜在的生物机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号